sábado, 23 de marzo de 2024

EMA Approves Ocular Formulation of Bevacizumab for Macular Degeneration Sheena Meredith, MBBS, MPhil March 22, 2024

https://www.medscape.com/viewarticle/ema-approves-ocular-formulation-bevacizumab-2024a10005gf?src=

No hay comentarios:

Publicar un comentario